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SUMMARY 
The thiol residues involved in two previously described modifications of heart 
lipoamide dehydrogenase (NADH :lipoamide oxidoreductase, EC 1.6.4.3) have been 
identified by comparison of peptide maps of unmodified and modified enzymes. Two 
thiols and one methionine react when native enzyme is alkylated in concentrated 
iodoacetamide, with the accompanying loss of enzymatic activity and an NAD- 
binding site. NAD protects the more slowly reacting thiol from alkylation, and the 
NAD-protected enzyme is active and retains its NAD-binding site. Loss of the binding 
site, and loss of activity are associated with the alkylation of two neutral thiol peptides 
which may represent alternative versions of a single thiol region in the enzyme. 
Treatment of native enzyme with cupric ion results in the rapid oxidation of two 
thiols to a disulfide bond and loss of NADH-lipoamide reductase activity. We have 
determined that thiol residues in the cationic peptide and one of the anionic peptides 
are involved in the disulfide bond formed by cupric ion. Since the cationic peptide 
contains two histidyl residues, it is proposed that it is the initial site of binding of 
cupric ion, prior to the oxidation of the thiol residues to a disulfide bond. 
INTRODUCTION 
Lipoamide dehydrogenase (NADH:lipoamide oxidoreductase, EC 1.6.4.3) 
accepts and donates 2 electrons in its catalytic cycle [1]. Since the enzyme contains 
both FAD and a redox active disulfide, it can accept 4 electrons under various forcing 
conditions. Reduction in the presence of arsenite leads to 4-electron reduction (and 
to inactivation in the lipoate reaction) due to the formation of a covalent adduct 
between the vicinal dithiol and the arsenite. If this reduction has been effected with 
NADH, resulting in the formation of NAD, the spectrum of the reduced enzyme 
displays a broad long wavelength absorption centering around 700 nm due to 
charge-transfer interaction between FADH2 and NAD [2, 3]. 
Stein and Stein [4] have shown that alkylation of native pig heart lipoamide 
Abbreviation: DTNB, 5,5'-dithiobis(2-nitrobenzoic acid). 
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dehydrogenase by concentrated iodoacetamide is associated with a 95 ~ decrease in 
the NADH-lipoamide reductase activity of the enzyme and with loss of the ability 
to form the 700 nm charge-transfer band. Since the formation of this band is abso- 
lutely dependent on the presence of pyridine nucleotide, they interpreted their results 
as indicating that the alkylation had destroyed the NAD-binding site by reactio, n 
with a thiol. They did not, however, demonstrate that a thioi was the site of alkylation. 
They indicated that the alkylated enzyme could be reduced to the red 2-electron 
intermediate by I equivalent of NADH. 
Treatment of native enzyme with cupric ion also leads to a 90-95 ~ reduction 
in the NADH-lipoamide reductase activity of the enzyme. Although this enzyme is 
also capable of reduction by either NADH or reduced lipoamide these proceed at a 
much slower rate [5]. Veeger and Massey [5] and Casola et al. [6] have presented 
data indicating that the inactivation of the enzyme involves the formation of a new 
disulfide bond from two of the thiols of native enzyme. 
Since the enzyme contains seven to eight thiol groups per mole of enzyme 
bound FAD [7] we wished to be able to distinguish those thiol groups which were 
modified by treatment of heart lipoamide dehydrogenase with cupric ion, and by 
alkylation of the native enzyme in concentrated iodoacetamide. In this way we hoped 
to reach a clearer understanding of the role of thiols in the catalytic activity of the 
enzyme. A preliminary report on some of the work presented here has appeared [8]. 
MATERIALS AND METHODS 
The methods for preparation of pig heart lipoamide dehydrogenase, for 
5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) titrations of enzyme thiol groups, for 
anaerobic experiments, for alkylation and digestion of the denatured enzyme, and 
for the preparation of two-dimensional peptide maps, as well as the peptide number- 
ing system are given previously [7]. 
Conditions for amino acid analysis of samples of modified enzyme were the 
same as those described previously [7] for amino acid analysis of peptides, except that 
/%mercaptoethanol was not added to the 6 M HC1 used to digest samples of whole 
protein. Alkylated methionine was estimated by summing the areas under the peaks 
for S-carboxymethylhomocysteine, homoserine and homoserine lactone [9]. 
NADH-lipoamide reductase assays were performed essentially as described by 
Massey [10] using 3 ml vol. containing 0.05 M phosphate buffer, pH 6.3; bovine 
serum albumin, 2 mg; NADH 0.3 #mole; NAD, 0.2 #mole; D,L-lipoamide, 2 #moles. 
Inactivation of pig heart lipoarnide dehydrogenase by cupric ion 
The enzyme (100 nmoles/ml) was dialyzed against two 1-1 changes of glass- 
distilled, deionized water to remove all EDTA and buffer. The dialyzed enzyme was 
brought to 0.03 M in phosphate buffer, pH 7.6. An 8-fold excess of cupric sulfate 
over enzyme-bound FAD was added, and the solution incubated on ice for 30 rain. 
A 10-fold excess of neutralized EDTA over copper sulfate was then added to quench 
the reaction, and the copper-EDTA complex was separated from the enzyme by 
passage over a Sephadex G-25 column equilibrated with 0.1 M phosphate (pH 7.6)- 
0.4 mM EDTA, On addition of cupric ion to the enzyme solution, a light precipitate 
forms, indicating that the solubility product for cupric phosphate has been exceeded. 
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Therefore, the actual excess of soluble cupric ion over enzyme-bound FAD must be 
significantly less than 8-fold. However for consistancy of comparison of our results 
with earlier experiments in our own laboratory, and with the results of Casola et al. [6] 
who used substantially the same procedure for copper inactivation, the conditions 
of inactivation were not changed. Before and after the inactivation with cupric ion, 
the enzyme was assayed according to Casola et al. [6] for both lipoic acid reductase 
and diaphorase activities. 
Modification of the enzyme ushlg concentrated iodoacetamide 
Native pig heart lipoamide dehydrogenase was inactivated by iodoacetamide 
according to the method suggested by Dr Abraham Stein (personal communication). 
The enzyme was incubated for 24 h, at 25 °C, in the dark, in a solution which was 
0.1 M in both iodoacetamide and phosphate buffer, pH 7.2. At the completion of the 
reaction, the excess iodoacetamide was removed by passage over a Sephadex G-25 
column. For studies of the effect of NAD on alkylation by concentrated iodoacet- 
amide, a neutralized 0.5 M solution of NAD was prepared by addition of NaOH. 
Alkylation of the NAD-protected enzyme was performed in solutions which were 
0.1 M in NAD, iodoacetamide and phosphate buffer, pH 7.2. Assays of the enzyme 
during the course of alkylation were performed by diluting a 10/~1 aliquot of enzyme 
into 90 ,ul of 0.1 M cysteine (cysteine.HCl neutralized with NaOH to pH 7) and 
waiting 10 min for all iodoacetamide to react. Aliquots of enzyme-cysteine solution 
were then added to assay mixtures. Additions of comparable aliquots of 0.09 M 
cysteine to assay mixtures, containing native enzyme showed no influence on the 
measured activity in the NADH-lipoamide reductase assay. This technique could not 
be used to measure diaphorase activity since cysteine reacts rapidly with 2,6-dichloro- 
indophenol in a non-enzymatic reaction. 
RESULTS AND DISCUSSION 
Modification with concentrated iodoacetamide 
Enzyme inactivated by alkylation in 0.1 M iodoacetamide shows 4-7 % of its 
original lipoamide reductase activity in agreement with the activity reported by Stein 
and Stein [4] and approx. 60 ~o of its original diaphorase activity. There is no apparent 
dissociation of flavin from the alkylated enzyme; on passage of the modified enzyme 
over Sephadex G-25, all the fluorescence and yellow color are associated with the 
protein fraction. Anaerobic reduction of the alkylated enzyme results in the appar- 
ently complete formation of the red 2-electron reduced enzyme, (the form seen as the 
intermediate in catalysis) with either NADH or reduced lipoamide as the reductant. 
This indicates that the residual 5 % lipoamide reductase activity of alkylated enzyme 
is not due to 5 % unmodified enzyme, but must be due to all of the enzyme turning 
over at a diminished rate. 
The two halves of Fig. 1 compare the ability to form the NAD-dependent 
charge-transfer complex in enzyme alkylated in the absence or presence of NAD. 
The upper section of Fig. 1 shows our repetition of an experiment reported by Stein 
and Stein [4] in which enzyme previously alkylated with concentrated iodoacetamide 
is subjected to anaerobic reduction by an 8-fold excess of NADH over enzyme-bound 
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Fig. I .  ( I )  Spectrum of enzyme modified by alkylation in concentrated iodoacetamide as described 
in the text. Alkylation was allowed to proceed for 24 h and then the excess reagents were removed. 
1he  enzyme was dissolved in 0.1 M phosphate buffer, pH 7.6 containing 0.3 m M  E D T A  and 1 m M  
sodium arsenite. (2) Enzyme after anaerobic addition of 8 equivalents N A D H  per enzyme-bound 
FAD.  (3) Spectrum of enzyme modified by alkylation by concentrated iodoacetamide in the presence 
of N A D  as described in the text. The alkylation was allowed to proceed for 2 h and then the excess 
reagents were removed. The enzyme was dissolved in the buffer system described in (1). (4) Enzyme 
after anaerobic addition of 8 equivalents of N A D H  per enzyme-bound FAD.  
enzyme. There is no long wavelength band formed upon reduction, although at least 
2 equivalents of N A D  have been produced. In comparison, in Fig. 1, lower section, 
we have shown that enzyme alkylated under the same conditions, but in the presence 
of 0.1 M N A D  (later removed), retains its pyridine nucleotide binding site as evi- 
denced by the formation of the green charge-transfer complex between N A D  and 
FADHz. 
We have determined that alkylation of unprotected enzyme results in the 
carboxymethylation of two thiols and one methionine, and the time course of the 
alkylation is shown in Fig. 2. Comparison of the time course of alkylation in the 
presence and absence of N A D  demonstrates that substantial protection against 
alkylation is afforded by the NAD.  The spike in activity of the N A D  protected 
enzyme during alkylation is not always observed. The inset shows the results of 
amino acid analysis of samples of enzyme taken at intervals during alkylation. It can 
be seen that methionine and one of the two thiols alkylate within 2 h in both unpro- 
tected and NAD-protected enzyme, and that NAD-protected enzyme is fully active 
at this stage in alkylation. Loss in activity appears to be associated with the alkylation 
of a second thiol which is substantially protected by NAD.  
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Fig. 2. The time course of alkylation of unprotected (~) and NAD-protected ((3)heart lipoamide 
dehydrogenase. The alkylations and assays for activity of the enzyme were performed as described 
in the text. The inset summarizes the results of amino acid analyses performed on aliquots of enzyme 
solutions which were removed at intervals during the alkylation. A 5-fold excess of/~-mercaptoethanol 
over iodoacetamide present in the aliquot was added to stop the reaction, and after 30 rain the sample 
was prepared for hydrolysis. 
If the unprotected enzyme is treated with unlabelled iodoacetamide for 24 h, 
so that two thiols and one methionine are alkylated, it can then be realkylated in the 
presence of  dithiothreitol and guanidine, using iodo[14C1]acetate and digested with 
trypsin. Any thiol peptide alkylated with iodoacetamide should now be missing from 
the radioautogram of a two-dimensional chromatography-electrophoresis of the 
digest. Fig. 3 shows such a radioautogram. Three thiol peptides, Peptides 16, 18 and 
51, normally seen in maps of reduced alkylated lipoamide dehydrogenase, are com- 
pletely missing [7]. Identification of the labelled peptides is greatly assisted by staining 
the entire map with cadmium-ninhydrin, since the characteristic colors and grouping 
of  the peptides are quite reproducible from one map to another, even though small 
differences in the chromatography or electrophoresis of a given peptide may occur. 
If NAD-protected enzyme is alkylated for 2 h with unlabelled iodoacetamide, 
so that one thiol and one methionine are alkylated, the enzyme can be realkylated 
with iodo[14C1]acetate after incubation with dithiothreitol and guanidine, digested 
with trypsin, and peptide maps prepared. Radioautograms of enzyme prepared in 
this manner show no missing spots, but look identical to radioautograms of untreated 
enzyme, alkylated with iodo[t4Cl]acetate after reduction with dithiothreitol in 
guanidine. 
Matthews et al. [7] demonstrated that Peptide 18 is derived from Peptide 51 
by chymotryptic cleavage, and gave less conclusive evidence suggesting that Peptide 16 
may be a related sequence. If  Peptides 16 and 18-51 represent alternative sequences of 
a given thiol region, their absence demonstrates the alkylation of only one thiol group 
per enzyme-bound FAD. The radioactive label in Peptide 16 accounts for only l0 
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Fig. 3. A radioautogram of a peptide map of enzyme alkylated for 24 h with unlabelled concentrated 
iodoacetamide as described in the text, and then denatured, reduced and alkylated with iodo[laC]- 
acetate, and digested with trypsin. The peptide map was prepared as described in the text. The origin 
is at the top on the vertical line. Descending chromatography was performed in the vertical dimension 
and pH 6.5 electrophoresis in the horizontal dimension. The cathode was to the left of the origin and 
the anode to the right. The numbers associated with dashed lines indicate the positions on the map 
where peptides, seen in maps of unmodified enzyme, are absent. 
of  one thiol per F A D ,  while the label in Peptides 18 and 51 accounts for 70~o of  
one thiol. 
The thiol which is rapidly alkylated by iodoacetamide is presumably located 
in one of  the two reactive thiol regions which are not  released by tryptic cleavage. 
These regions have been isolated by Brown and Perham [11] using t rypt ic -chymo-  
tryptic digestions and have been sequenced. The sequences (Peptides D T C I a  and 
D T C l b 3 )  are shown in Table 1V of Matthews et al. [7]. The thiol which reacts rapidly 
with iodoacetamide is not unreactive to iodoacetate,  since the same number  of  thiol 
groups (8.3) are alkylated whether enzyme is reduced and alkylated with iodoacetate,  
or first reacted with iodoacetamide and then reduced and alkylated with iodoacetate. 
Thus the thiol in Peptide 16 and/or  the thiol in Peptide 18-51 appears to be 
at or very near an NAD-b ind ing  site on the enzyme, and its alkylation leads to loss of 
this binding site. 
The loss o f  the NAD-bind ing  site is evidenced by abolition o f  the charge- 
transfer complex between F A D H z  and N A D .  But N A D  also protects oxidized 
enzyme against alkylation, presumably by binding so as to mask the thiol at or near 
the NAD-b ind ing  site which functions in reduced enzyme. Thus, we feel that  oxidized 
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enzyme must also bind NAD at the same site as in reduced enzyme. Small spectral 
changes are indeed observed when NAD is added to oxidized enzyme [12] or to the 
red catalytic intermediate [13]. 
There is experimental evidence that oxidized enzyme contains two distinct 
pyridine nucleotide binding sites [2, 12, 14]. It is reasonable to suppose that one of 
these sites represents the catalytic binding site for NADH or NAD since in vitro the 
enzyme catalyzes a reversible reaction. The NAD-binding site lost on alkylation is 
not the catalytic binding site, because the alkylated enzyme is still capable of catalysis 
albeit at a slower rate. A question might be raised as to whether loss of the green 
charge-transfer complex necessarily reflects loss of a pyridine nucleotide binding site. 
The charge-transfer complex could be abolished because the bound pyridine nucleo- 
tide was no longer sufficiently close to the flavin due to a conformational change 
induced by alkylation of the thiol group. But in this case, if alkylated enzyme were 
still to bind pyridine nucleotide, one would not expect the presence of NAD to 
protect against the alkylation of the thiol. 
It is tempting to equate the pyridine nucleotide binding site lost on alkylation 
with the NAD-binding site ("Y" site) proposed by Massey and Veeger [2] in their 
mechanism for lipoamide dehydrogenase. The "Y" site was proposed to explain the 
requirement for the presence of NAD in order to observe full NADH-lipoate reduc- 
tase activity. 
Recently Voetberg and Veeger [12] have presented data indicating that the 
role of NAD in the NADH-lipoate reaction is to lower the pK of a group functioning 
in catalysis in its deprotonated form, and they suggest that this group may be a thiol. 
If  this is the case, it is almost certainly the thiol which, when alkylated, prevents 
charge-transfer interaction between FADH2 and NAD. 
Enzyme modified by cupric ion 
We have attempted to identify the thiols which are oxidized to form a disulfide 
bond when heart lipoamide dehydrogenase is inactivated by cupric ion. The thiol 
titer of native enzyme reacted with DTNB is 6.9-7.0, but after treatment with cupric 
ion the titer drops to 4.9-5.3. The treated enzyme shows NADH-lipoamide reductase 
activity which is 4 -10~  that of native enzyme, and diaphorase activity which is 
10-15-fold higher than native enzyme. If the copper-treated enzyme is anaerobically 
reduced by NADH in the presence of 1 mM arsenite (cf. the experiment in Fig. 1) 
there is complete formation of the green charge-transfer complex, and the spectrum 
of the reduced enzyme is indistinguishable from that of native enzyme reduced in the 
same way [5]. This led us to believe that the thiols involved in the disulfide bond 
formed on copper inactivation must not be the same as the thiol responsible for 
inactivation during alkylation in concentrated iodoacetamide. We attempted to 
identify the thiols oxidized during treatment with cupric ion by performing the follow- 
ing paired experiment. Enzyme was inactivated with cupric ion and the cupric ion 
removed. Cupric ion acts catalytically to oxidize the thiols to a disulfide and can be 
readily removed by dialysis [5]. The enzyme was divided into two fractions. Fraction 1 
was alkylated with iodo[a4C1]acetate and then was reduced with dithiothreitol and 
realkylated with unlabelled iodoacetate. Fraction 2 was first alkylated with unlabelled 
iodoacetate and then reduced and realkylated with iodo[a4C~]acetate. The alkylations 
were carried out in 7.5 M guanidine. HCI. Both fractions were digested with trypsin 
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and peptide maps prepared. In this manner thiols involved in the two disulfide bonds 
in enzyme treated with cupric ion should appear in radioautograms of Fraction 2 
and be absent in Fraction 1 radioautograms. The results of a typical experiment are 
shown in Fig. 4; the radioautogram of the Fraction 1 map is on the left and that of 
the Fraction 2 map is on the right. The two peptides (Peptides 15 and DS) repre- 
senting the active center disulfide [7] are prominent in Fraction 2 radioautograms, 
as expected. In addition, Peptides 20, 8 and 10 are more prominent in Fraction 2 
radioautograms than in Fraction 1 radioautograms. The interpretation of the results 
of experiments like these are subject to an important caveat. It is clear from the 
appearance of some labelled Peptide DS in Fraction 1 radioautograms that some 
disulfide interchange is taking place in copper-treated enzyme. This stands in contrast 
to native enzyme where the sam~ experiment leads to the almost total absence of 
Peptide DS from Fraction 1 radioautograms (Fig. 1, ref. 7). The conditions of efficient 
alkylation with iodoacetate, pH 8, 7.5 M guanidine, are obviously favorable for disulfide 
interchange and we have not been able to alkylate cupric ion-treated enzyme without 
some disulfide interchange. This may explain the fact that Peptides 8, 10 and 20 are 
~:~-15 ~--DS~'-8 
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Fig. 4. On the leR is a radioautogram of a peptide map of a tryptic digest of ]ipoamide dehydrogenase 
inactivated by cupric ion and alkylated as follows: the denatured enzyme is alkylated with iodo[14Cl]- 
acetate and then reduced and realkylated with unlabelled iodoacetate. On the right is a radioautogram 
of a peptide map of a tryptic digest of enzyme inactivated by cupric ion which has been denatured and 
alkylated with unlabelled iodoacetate and then reduced and realkylated with iodo[14C1]acetate. The 
preparation of the peptide map is described in the text, and the orientation of the maps is the same as 
the map in Fig. 3. Identical amounts of digested protein, as determined by amino acid analysis, 
25 nmoles, were used for the two peptide maps. 
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not completely absent from the Fraction I radioautograms. Matthews et al. [7] 
discuss the evidence indicating that Peptide 8 is derived from Peptide l0 by chymo- 
tryptic cleavage, secondary to the tryptic digestion. The relative amounts of Peptides 8 
and l0 produced in any given tryptic digestion seem to be quite variable. Thus the 
disulfide bond formed by the catalytic action of cupric ion appears to involve a 
unique pair of thiols, the thiol in Peptide 20 and that in Peptide 10-8. This implies 
that these two thiols lie reasonably close to one another in the three-dimensional 
structure of the native enzyme. It is of interest to speculate that their oxidation to a 
disulfide induces a strain in the molecule which disrupts the close juxtaposition of the 
flavin and the redox active disulfide. This juxtaposition is essential for the stability of 
the 2-electron reduced form that is functional in the lipoate reaction. The transient 
formation of this intermediate in cupric ion treated enzyme occurs upon reduction [5] 
indicating that the movement induced in the protein by the formation of a new 
disulfide is small. 
Dr Colin Thorpe, in our laboratory, has suggested that the histidines in 
Peptide 20 may serve to bind the cupric ion prior to metal catalyzed disulfide forma- 
tion. Brown and Perham [11] have sequenced the amino-terminal portion of Peptide 
20. Their sequence (Val-Cys(Cm)-His-Ala-His-Pro...) indicates that the histidines 
and this cysteine are indeed in close proximity to one another. There are several 
precedents for cupric ion binding to specific histidine residues in protein [15, 16]. 
Such an "anchoring" of the cupric ion to the protein, might help to explain the 
specificity and rapidity of the effect of cupric ion on a protein with so many thiol 
residues. 
Chemical modification of certain thiols in pig heart lipoamide dehydrogenase 
leads to profound alterations in the catalytic activities of this enzyme. Although 
lipoate reductase is lowered in both modifications of the enzyme discussed here, 
diaphorase activity is lowered on alkylation of the enzyme and raised on treatment 
with cupric ion. The pyridine nucleotide binding site associated with charge transfer 
between NAD and FADH2 is unaffected in the cupric ion treated enzyme while it is 
lost in enzyme reacted with iodoacetamide. The results reported here have established 
the identity of the cysteine residues involved in these modifications. The thiols 
oxidized to a disulfide by the catalytic action of cupric ion have been shown to be 
distinct from the thiols alkylated by iodoacetamide. 
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